Public Profile

Datwyler Pharma Packaging USA, Inc.

Datwyler Pharma Packaging USA, Inc., a leading player in the pharmaceutical packaging industry, is headquartered in the United States. Established in 1915, the company has built a strong reputation for its innovative solutions in primary packaging, particularly for injectable drugs and biopharmaceuticals. With major operational regions across North America, Datwyler is renowned for its high-quality elastomeric components, including stoppers and seals, which are essential for ensuring the safety and efficacy of pharmaceutical products. The company’s commitment to quality and compliance with stringent regulatory standards has positioned it as a trusted partner for pharmaceutical manufacturers. Notable achievements include advancements in sustainable packaging solutions and a robust portfolio that caters to the evolving needs of the healthcare sector. Datwyler Pharma Packaging continues to lead the market with its focus on innovation and customer-centric services.

DitchCarbon Score

How does Datwyler Pharma Packaging USA, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

27

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Datwyler Pharma Packaging USA, Inc.'s score of 27 is lower than 55% of the industry. This can give you a sense of how well the company is doing compared to its peers.

45%

Let us know if this data was useful to you

Datwyler Pharma Packaging USA, Inc.'s reported carbon emissions

Datwyler Pharma Packaging USA, Inc., headquartered in the US, currently does not have available carbon emissions data for the most recent year, nor does it specify any reduction targets or climate commitments. Without specific emissions figures or defined initiatives, it is unclear how the company is addressing its carbon footprint or contributing to climate action within the pharmaceutical packaging industry. As the industry increasingly focuses on sustainability, Datwyler's future commitments and strategies will be essential in understanding its role in reducing environmental impact.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Datwyler Pharma Packaging USA, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Datwyler Pharma Packaging USA, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Datwyler Pharma Packaging USA, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers